首页 | 本学科首页   官方微博 | 高级检索  
检索        

西利宾胺在肺结核治疗中护肝疗效
引用本文:朱杰,余连锋,王良玉,陈铁军.西利宾胺在肺结核治疗中护肝疗效[J].现代预防医学,2012,39(12):3104-3105.
作者姓名:朱杰  余连锋  王良玉  陈铁军
作者单位:1. 浙江省慈溪市疾病预防控制中心,浙江慈溪,315300
2. 慈溪市中医医院结核门诊
摘    要:目的观察西利宾胺在肺结核治疗中护肝疗效。方法采用西利宾胺和世界卫生组织推荐的短化方案治疗608例单纯菌阳肺结核(治疗组),并以同期短化治疗的552例作为对照(对照组)。结果治疗组初、复治菌阳肺结核患者肝功损害率分别为2.35%、5.10%,对照组分别为4.19%、18.18%,前两者差异无统计学意义(P﹥0.05),后两者差异有统计学意义(P﹤0.01)。结论在初治单纯肺结核时,无需常规加用护肝药,复治治疗则需考虑联用护肝药。

关 键 词:结核    护肝  西利宾胺

Protective effect of Silybin Meglumine on liver-injury in the treatment of pulmonary tuberculosis
ZHU Jie , YU Lian-feng , WANG Liang-yu , Chen Tie-jun.Protective effect of Silybin Meglumine on liver-injury in the treatment of pulmonary tuberculosis[J].Modern Preventive Medicine,2012,39(12):3104-3105.
Authors:ZHU Jie  YU Lian-feng  WANG Liang-yu  Chen Tie-jun
Institution:ZHU Jie*, YU Lian-feng, WANG Liang-yu, Cheng Tie-jun. *Cixi Center for Disease Prevention and Control, Cixi, Zhejiang 315300, China
Abstract:OBJECTIVE To observe the protective effect of Silybin Meglumine on liver-injury occurring in the course of pulmonary tuberculosis treatment. METHODS 608 simple smear-positive patients (treated group) were administrated with the combination of Silybin Meglumine and short-course chemotherapy of the WHO, while 552 patients (control group) were received short-course chemotherapy. RESULTS The incidence of liver function impairment of initial treatment patients was 2.35% in the treated group and 4.19% in the retreatment patients (P﹥0.05). However, the rates in the control group were 5.10% and 18.18%, respectively (P﹤0.01). CONCLUSION Liver protective agent is not necessary for simple pulmonary tuberculosis patients during initial treatment, while during retreatment, which is considered to be necessary.
Keywords:Tuberclosis  Pulmonary  Liver-curing  Silybin Meglumine
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号